Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,784 total articles

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Abivax SA announced that it will present nine scientific abstracts at Digestive Disease Week 2026 highlighting comprehensive efficacy, safety, and patient-reported outcomes of obefazimod, its lead drug candidate for moderately to severely active ulcerative colitis. Data from Phase 3 ABTECT trials and preclinical anti-fibrotic models demonstrate the…

First Merchants Corporation Announces First Quarter 2026 Results

First Merchants Corporation Announces First Quarter 2026 Results

First Merchants Corporation reported a net income of $27.7 million for Q1 2026, impacted by acquisition-related expenses and a mark-to-market loss on mortgage loans. On an adjusted basis excluding these charges, earnings increased compared to the prior year. The acquisition of First Savings Financial Group was completed, contributing significant as…

SoundHound AI To Report 2026 First Quarter Financial Results, Host Conference Call and Webcast on May 7

SoundHound AI To Report 2026 First Quarter Financial Results, Host Conference Call and Webcast on May 7

SoundHound AI, a leader in voice and conversational AI technology, will report its financial results for the first quarter of 2026 on May 7, followed by a conference call and webcast to discuss the results. The company provides AI solutions across multiple sectors including retail, financial services, healthcare, automotive, smart devices, and rest…

Reliance, Inc. Reports First Quarter 2026 Financial Results

Reliance, Inc. Reports First Quarter 2026 Financial Results

Reliance, Inc. (NYSE: RS) delivered a strong Q1 2026 financial performance, achieving $4 billion in net sales, a 37% year-over-year increase in non-GAAP EPS to $5.16, and a 33% rise in pretax income to $349.5 million. The company outperformed industry shipment trends with a 9.4% sequential increase in tons sold. They secured significant U.S. govern…

TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market

TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market

TOMI Environmental Solutions announced a major upgrade to its SteraMist iHP disinfection robot, redesigning it into a more agile, humanoid, and autonomous system. The company aims to serve rapidly expanding industries like robotaxi services that demand rigorous, automated decontamination. A key strategic move includes localizing the robot's power s…

Horizon Bancorp, Inc. Reports First Quarter 2026 Results, Highlighted by Continued Peer Leading Profitability Metrics and Solid Capital Growth

Horizon Bancorp, Inc. Reports First Quarter 2026 Results, Highlighted by Continued Peer Leading Profitability Metrics and Solid Capital Growth

Horizon Bancorp, Inc. announced robust first quarter 2026 financial results highlighted by steady profitability metrics with a 1.62% return on average assets and a durable 4.29% net interest margin. The company achieved 11% annualized growth in core deposits, driven by significant gains in non-interest-bearing balances, supporting disciplined comme…

Getty Realty Corp. Announces First Quarter 2026 Results

Getty Realty Corp. Announces First Quarter 2026 Results

Getty Realty Corp. announced its Q1 2026 financial results, highlighting a 72% increase in net earnings per share to $0.43 and a corresponding increase in Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO). The company invested $30.3 million in 29 properties with an 8.0% initial cash yield, extended leases reducing near-term leas…

Appian Corporation to Host Investor Day on May 14, 2026

Appian Corporation to Host Investor Day on May 14, 2026

Appian Corporation, a provider of process automation technology, will hold an Investor Day on May 14, 2026, in New York City. The event will feature presentations by executives and customers highlighting the use of Appian’s platform. The event aims to provide investors deeper insights into the company's operations and market position.

LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

LB Pharmaceuticals announced the publication in JAMA Psychiatry of positive Phase 2 clinical trial results for LB-102 in treating schizophrenia. LB-102 demonstrated statistically significant benefits versus placebo including rapid onset, sustained efficacy, and a favorable safety profile. The company is currently conducting a pivotal Phase 3 trial …

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. (Nasdaq: PETS) announced a strategic partnership with Rural King to launch a pet pharmacy service across Rural King's retail stores and digital platforms. PetMeds will provide pharmacy infrastructure, licensed pharmacists, and e-commerce capabilities, expanding access to pet prescription medications and health products nationwi…

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

BridgeBio Oncology Therapeutics announces preclinical data showcasing BBO-11818, a selective oral inhibitor targeting multiple KRAS mutations in both active and inactive states, demonstrating robust anti-tumor effects alone and in combination therapies in models of pancreatic, lung, and colorectal cancers. Updated Phase 1 trial data expected in lat…

Goosehead Insurance, Inc. Announces First Quarter 2026 Results

Goosehead Insurance, Inc. Announces First Quarter 2026 Results

Goosehead Insurance, Inc. announced its Q1 2026 financial results, showcasing strong growth with total revenues up 23% year-over-year to $93.1 million and net income rising to $8.0 million from $2.6 million. Core revenues increased 15% driven by higher renewal and new business commissions, while total written premiums grew 13% to $1.1 billion. The …